DPP4 and metabolic dysfunction-associated steatotic liver disease: Reductions in the EtOH‐mediated hyperexpression of DPP‐4 illustrate the ability of DHM to mediate insulin resistance associated with elevated hepatic DPP‐4 and nonalcoholic fatty liver disease (NAFLD; Baumeier et al., 2017).